Richmond News
Actor from “Kim’s Convenience” will host acting workshops at Richmond organization
Students aged seven to 19 interested in acting and improving their communication skills are welcome to join the acting workshop with James Yi
2020: Richmond comes together as the pandemic touches the community
One in a series of four stories from British Columbian communities reflecting on how they dealt locally with the pandemic in 2020. 2020 has been anything but auspicious, but it certainly will be...
Business case for Massey Tunnel replacement plan yet to be presented
The BC NDP previously promised the business case would be made public in the fall
Preferred option for Massey Tunnel replacement chosen
Both options include the closure of the existing tunnel
Richmond financial agents coached client to lie to an investigator: BCSC
FS Financial Strategies' employees acted out scenarios with a client, prior to an investigator calling
‘Death by 1,000 cuts’ for 102 Fraser River estuary species at risk of extinction
More than 100 animal species in the Fraser River estuary could be “functionally extinct” within the next 25 years, unless an overarching, multi-government plan is put in place to save them, a new...
Violating B.C. mask order can result in a $230 fine
If you're planning to go shopping or head to an indoor public space, remember to bring a mask or you could be fined under the new provincial health order (PHO). B.C.'s Minister of Public Safety and...
Third COVID vaccine trials successful
A third drug company has announced a high success rate during the late stages of testing for a COVID-19 vaccine. AstraZeneca said Monday that its vaccine with Oxford University in England was up to...
Need the smell of 11 herbs and spices in your home? Here's where to buy KFC's fried chicken fire logs in Metro Vancouver
Chestnuts roasting on an open fire? Nah. Gimme the scent of fried chicken, please.
Another COVID vaccine appears to have high success rate
For the second Monday in a row, a pharmaceutical giant has announced advances in finding a COVID-19 vaccine. U.S.-based Moderna said Monday morning that its “vaccine candidate” had a 94.5 per cent...